Plasma microRNAs as prognostic biomarkers for development of severe epilepsy after experimental traumatic brain injury-EpiBioS4Rx Project 1 study.

Autor: Heiskanen M; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Ndode-Ekane XE; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Ali I; Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Santana-Gomez C; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Puhakka N; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Gupta SD; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Andrade P; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Immonen R; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Casillas-Espinosa P; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Manninen E; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Smith G; UCLA Brain Injury Research Center, Department of Neurosurgery, David Geffen School of Medicine, & UCLA Intellectual and Developmental Disabilities Research Center, University of California at Los Angeles, Los Angeles, California, USA., Brady RD; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Silva J; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Braine E; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Hudson M; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Yamakawa GR; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Jones NC; Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Shultz SR; Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia., Harris NG; UCLA Brain Injury Research Center, Department of Neurosurgery, David Geffen School of Medicine, & UCLA Intellectual and Developmental Disabilities Research Center, University of California at Los Angeles, Los Angeles, California, USA., Wright DK; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Gröhn O; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Staba RJ; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., O'Brien TJ; Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia., Pitkänen A; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Publikováno v: Epilepsia [Epilepsia] 2024 Dec 11. Date of Electronic Publication: 2024 Dec 11.

Plasma neurofilament heavy chain is a prognostic biomarker for the development of severe epilepsy after experimental traumatic brain injury.

Autor: Heiskanen M; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Banuelos I; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Manninen E; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Andrade P; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Hämäläinen E; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Puhakka N; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Pitkänen A; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Publikováno v: Epilepsia [Epilepsia] 2024 Dec; Vol. 65 (12), pp. 3703-3716. Date of Electronic Publication: 2024 Oct 14.

A novel multigrid method for electronic structure calculations

Autor: Heiskanen, M., Torsti, T., Puska, M. J., Nieminen, R. M.

Publikováno v: Phys. Rev. B 63, 245106 (2001)

A general real-space multigrid algorithm for the self-consistent solution of the Kohn-Sham equations appearing in the state-of-the-art electronic-structure calculations is described. The most important part of the method is the multigrid solver for t

Externí odkaz: http://arxiv.org/abs/cond-mat/0101233

Image data harmonization tools for the analysis of post-traumatic epilepsy development in preclinical multisite MRI studies.

Autor: Bhagavatula S; USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA. Electronic address: swetab@usc.edu., Cabeen R; USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA., Harris NG; Department of Neurology, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA., Gröhn O; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Wright DK; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Garner R; USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA., Bennett A; USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA., Alba C; USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA., Martinez A; USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA., Ndode-Ekane XE; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Andrade P; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Paananen T; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Ciszek R; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Immonen R; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Manninen E; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Puhakka N; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Tohka J; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Heiskanen M; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Ali I; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Shultz SR; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Casillas-Espinosa PM; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Yamakawa GR; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Jones NC; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Hudson MR; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Silva JC; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Braine EL; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Brady RD; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Santana-Gomez CE; Department of Neurology, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA., Smith GD; Department of Neurology, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA., Staba R; Department of Neurology, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA., O'Brien TJ; Departments of Neuroscience and Neurology, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia., Pitkänen A; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Duncan D; USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.

Publikováno v: Epilepsy research [Epilepsy Res] 2023 Sep; Vol. 195, pp. 107201. Date of Electronic Publication: 2023 Aug 02.

Predicting online problem gambling treatment discontinuation: New evidence from cross-validated models.

Autor: Palomäki J; Gambling Clinic, Helsinki University Hospital., Lind K; Finnish Institute for Health and Welfare, Health and Well-Being Promotion Unit., Heiskanen M; Finnish Institute for Health and Welfare, Health and Well-Being Promotion Unit., Castrén S; Finnish Institute for Health and Welfare, Health and Well-Being Promotion Unit.

Publikováno v: Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors [Psychol Addict Behav] 2023 May; Vol. 37 (3), pp. 519-532. Date of Electronic Publication: 2022 Aug 18.